Characteristics of Complement Protein Deposition in Proliferative Glomerulonephritis with Monoclonal Immunoglobulin Deposition
Meng-Yao Liu,Xiao-Juan Yu,Su-Xia Wang,Yuan Li,Guo-Lan Xing,Ming Chen,Fu-de Zhou,Ming-Hui Zhao,Meng-yao Liu,Xiao-juan Yu,Su-xia Wang,Guolan Xing,Ming-hui Zhao
DOI: https://doi.org/10.2215/cjn.0000000000000295
IF: 10.6233
2023-09-15
Clinical Journal of the American Society of Nephrology
Abstract:Background: Hypocomplementemia and complement co-deposition with monoclonal immunoglobulins in glomeruli are not rare in proliferative glomerulonephritis with monoclonal immunoglobulin deposits (PGNMID). Deposition of monoclonal immunoglobulins in glomeruli has been suggested to activate complement and cause kidney injury. However, the profiles of complement activation in PGNMID and their clinical and pathological significance need to be clarified. Methods: Forty-six patients with PGNMID were enrolled. Proteomic analysis of glomeruli using laser microdissection and mass spectrometry (LMD/MS) was performed for ten PGNMID patients to determine the composition of glomerular deposits. Kidney deposition of complement components was detected by immunohistochemistry and immunofluorescence. Urinary and plasma levels of complement components were measured by enzyme-linked immunosorbent assay. Group differences were assessed using t tests or Mann–Whitney U tests depending on the distribution. Correlation analysis was performed using Spearman's rank correlation or Pearson’s correlation. Results: LMD/MS-based proteomic analysis showed that complement components were the most enriched proteins deposited in the glomeruli of PGNMID patients. Glomerular deposition of C3c, C4d, and C5b-9 was detected in most patients. Levels of urinary and plasma C3a, C5a, soluble C5b-9, C4d, Bb, and C1q as well as urinary mannose-binding lectin were significantly higher in PGNMID patients compared to healthy controls. The intensity of C3c and C4d deposition in glomeruli correlated with serum creatinine and the percentage of crescents, respectively. Furthermore, levels of urinary complement components correlated positively with serum creatinine, urinary protein excretion, the percentage of crescents and global glomerulosclerosis in kidney biopsies, while plasma levels of most complement components did not show a significant correlation with clinicopathological parameters. In multivariable analysis, a higher level of urinary C4d was identified as an independent risk factor for kidney failure. Conclusions: The complement system was found to be overactivated in PGNMID, and levels of urinary complements correlated with disease severity. A higher level of urinary C4d was identified as an independent risk factor for kidney failure.
urology & nephrology